Dr. Roach Backs 40 mg Rosuvastatin for LDL 199, With Room to Start Lower

Q: Could your daily zero-calorie diet soda habit secretly be altering your gut bacteria and setting you up for long-term weight gain?

Possibly, but the evidence is not strong enough to say your daily diet soda habit is secretly causing long-term weight gain. What the evidence does show is that zero-calorie sweeteners in diet soda do not usually raise blood sugar or A1C much in the short term on their own. That matches Dr. Roach’s advice and guidance from major medical sources. For someone replacing regular soda, diet soda is generally the less harmful choice. The uncertainty is in the long term. Some human studies have linked frequent artificial sweetener use with higher risks of weight gain, diabetes, or other metabolic problems, but those studies are observational. That means they cannot prove diet soda is the cause, because people already at risk for weight gain often choose diet drinks in the first place. There is also growing microbiome research. A 2026 Cambridge laboratory study found that many sweeteners directly changed the growth of gut bacteria, and that their effects could shift when combined with things like caffeine, flavorings, or medications. But those were lab experiments, not studies in people, so it is still unclear whether the same changes happen in the body or lead to real-world weight gain. A more established risk is dental. Diet soda is acidic and, when sipped all day, can erode tooth enamel. The practical takeaway is that diet soda is better than sugary soda, but it is not a free pass. If it is your main drink all day, cutting back is sensible. Water remains the best default choice.

1 articles · Updated · Detroit News · Aug 14

LDL of 199 mg/dL puts the patient in a group where treatment benefits clearly outweigh risks, and Dr. Roach said 10 out of 10 cardiologists would recommend a statin.
Rosuvastatin 40 mg plus Ezetimibe 10 mg is an aggressive but reasonable regimen, he said, because ezetimibe is not a second statin and lowers cholesterol by blocking absorption in the gut.
The main debate is dose: some clinicians reserve 40 mg rosuvastatin for patients with known blockages, while others favor starting with the most effective therapy.
An alternative is beginning with a lower statin dose and titrating up to reach an LDL goal below 70 mg/dL—some experts would target 50—while tailoring treatment with a primary care doctor.